A detailed history of Core Alternative Capital transactions in Danaher Corp stock. As of the latest transaction made, Core Alternative Capital holds 2,422 shares of DHR stock, worth $600,074. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,422
Previous 2,450 1.14%
Holding current value
$600,074
Previous $611,000 0.98%
% of portfolio
0.12%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

SELL
$235.51 - $267.98 $6,594 - $7,503
-28 Reduced 1.14%
2,422 $605,000
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $2,919 - $3,330
-13 Reduced 0.53%
2,450 $611,000
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $196,206 - $247,117
-1,060 Reduced 30.09%
2,463 $569,000
Q3 2023

Oct 19, 2023

SELL
$233.08 - $265.59 $318,154 - $362,530
-1,365 Reduced 27.93%
3,523 $874,000
Q2 2023

Jul 27, 2023

BUY
$224.99 - $256.14 $67,721 - $77,098
301 Added 6.56%
4,888 $1.17 Million
Q1 2023

Apr 18, 2023

SELL
$239.75 - $277.0 $145,768 - $168,416
-608 Reduced 11.7%
4,587 $1.16 Million
Q4 2022

Jan 31, 2023

BUY
$241.42 - $282.29 $103,327 - $120,820
428 Added 8.98%
5,195 $1.38 Million
Q3 2022

Oct 18, 2022

BUY
$247.06 - $1507.4 $201,848 - $1.23 Million
817 Added 20.68%
4,767 $1.23 Million
Q2 2022

Aug 01, 2022

BUY
$237.11 - $299.66 $324,603 - $410,234
1,369 Added 53.04%
3,950 $1 Million
Q1 2022

May 10, 2022

BUY
$257.27 - $315.76 $478,007 - $586,682
1,858 Added 256.98%
2,581 $757,000
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $190,436 - $214,514
652 Added 918.31%
723 $238,000
Q3 2021

Nov 05, 2021

BUY
$272.21 - $332.43 $19,326 - $23,602
71 New
71 $22,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $180B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.